General Practice Doctors in Joliet, IL Accepting Medicare

6 General Practice doctors found. Showing 1 - 6

Dr. Abilio Milo, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 213 East Cass Street, Joliet, IL 60432 Phone: 815-726-3377    Fax: 815-726-2708

Dr. Alma Mia Rosal Martija, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1301 Copperfield Ave, Suite 206, Joliet, IL 60432 Phone: 815-726-2368    Fax: 815-774-4799

Dr. Raymond G Orenic, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 333 N Hammes Ave, Ste 108, Joliet, IL 60435 Phone: 815-744-7100    Fax: 815-744-7186

Corazon Balbarin, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1106 Neal Ave, Joliet, IL 60433 Phone: 815-727-8670

Dr. Desmond Thomas White, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 213 E Cass St, Joliet, IL 60432 Phone: 815-726-3377

Mr. Kul Sood, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 95 S Chicago St, Joliet, IL 60436 Phone: 815-740-5561    Fax: 815-740-5577

News Archive

Inconsistent SARS-CoV-2 antibody results in nephrology workers

Using a broad spectrum of antibody tests the present study revealed inconsistent results for SARS-CoV-2 seroprevalence among asymptomatic individuals, while this was not the case among Covid-19 patients.

Lantheus Medical Imaging announces preliminary data on flurpiridaz F 18 PET MPI agent

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced preliminary data on flurpiridaz F 18 (formerly known as BMS747158), its novel compound in development as a Positron Emission Tomography (PET) myocardial perfusion imaging (MPI) agent. The study of nine patients compared rest-stress flurpiridaz F 18 PET MPI, with rest-stress technetium-99m (Tc-99m) labeled single photon emission computed tomography (SPECT) for the detection and evaluation of coronary artery disease (CAD).

PCSK9 and HMGCR genetic variations that lower bad cholesterol affect risk of cardiovascular events

In a new study published in the December 1, 2016 issue of The New England Journal of Medicine, researchers at Brigham and Women's Hospital, and a collaboration of international researchers, studied variants in the genes encoding HMGCR and PCSK9 that affect cholesterol levels, and found that variants that lowered LDL (or "bad") cholesterol in each gene were associated with nearly identical protective effects on the risk of cardiovascular events per unit reduction in LDL cholesterol.

IHR Emergency Committee on COVID-19 urges focus on evidence-based response efforts

The Emergency Committee on COVID-19 met on 29 October to review the situation and progress made on the temporary recommendations. They advised that the pandemic still constituted a public health emergency of international concern, and urged a focus on response efforts based on lessons learned and strong science.

Read more Medical News

› Verified 9 days ago